NASDAQ:XFOR
X4 Pharmaceuticals
- Stock
Last Close
0.69
30/08 20:00
Market Cap
103.11M
Beta: 0.25
Volume Today
726.85K
Avg: 1.81M
PE Ratio
−1.27
PFCF: −1.65
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 623K - | 800.50K 28.49% | 177.50K 77.83% | |||||||
average payables | 1.03M - | 1.77M 71.08% | 1.22M 31.09% | 1.32M 8.00% | 2.62M 98.71% | 3.71M 41.95% | 6.03M 62.38% | 8.36M 38.67% | ||
average receivables | 1.44M - | 1.48M 2.32% | 2.23M 51.27% | 2.43M 8.73% | 1.46M 39.98% | 832K 42.92% | 949.50K 14.12% | 857K 9.74% | ||
book value per share | -36.98 - | -60.95 64.80% | 170.84 380.29% | 47.06 72.45% | 11.21 76.18% | 3.63 67.65% | 2.50 31.01% | 1.17 53.40% | 0.29 75.35% | |
capex per share | -0.18 - | -0.08 57.06% | -0.12 55.37% | -0.07 39.39% | -0.02 79.63% | -0.07 349.53% | -0.02 64.79% | -0.00 93.21% | -0.00 79.19% | |
capex to depreciation | -0.44 - | -0.26 41.39% | -0.22 15.91% | -0.22 1.84% | -1.69 670.13% | -3.88 129.70% | -1.23 68.24% | -0.20 83.71% | -0.03 85.03% | |
capex to operating cash flow | 0.02 - | 0.00 78.54% | 0.00 55.33% | 0.00 44.84% | 0.00 335.60% | 0.02 539.52% | 0.01 62.54% | 0.00 84.60% | 0.00 53.46% | |
capex to revenue | -0.01 - | -0.45 - | ||||||||
cash per share | 7.28 - | 3.27 55.10% | 223.47 6,732.96% | 67.00 70.02% | 10.94 83.67% | 3.92 64.18% | 3.18 18.98% | 1.92 39.68% | 0.64 66.40% | |
days of inventory on hand | ||||||||||
days payables outstanding | 1.64K - | |||||||||
days sales outstanding | 298.15 - | 111.57 - | ||||||||
debt to assets | 0.76 - | 2.01 165.80% | 0.18 91.09% | 0.22 22.44% | 0.14 34.97% | 0.31 119.46% | 0.34 8.51% | 0.25 27.27% | 0.38 53.09% | |
debt to equity | -0.21 - | -0.27 28.96% | 0.25 191.69% | 0.37 47.46% | 0.18 51.48% | 0.53 197.85% | 0.62 16.95% | 0.52 16.00% | 1.09 109.98% | |
dividend yield | 1.74 - | 0.16 - | ||||||||
earnings yield | -0.17 - | -0.29 73.82% | -1.29 337.83% | -6.73 422.91% | -0.46 93.19% | -0.48 4.90% | -1.50 212.54% | -1.49 1.08% | -0.68 54.40% | |
enterprise value | 78.55M - | 90.37M 15.05% | -38.25M 142.32% | -16.47M 56.94% | 20.10M 222.03% | 88.84M 341.97% | 16.96M 80.90% | -20.22M 219.18% | 107.91M 633.77% | |
enterprise value over ebitda | -6.36 - | -4.19 34.08% | 1.19 128.46% | 0.39 66.99% | -0.46 216.26% | -1.48 224.07% | -0.26 82.57% | 0.23 188.24% | -1.02 548.09% | |
ev to operating cash flow | -7.26 - | -4.18 42.50% | 1.37 132.86% | 0.40 70.66% | -0.42 203.87% | -1.51 261.09% | -0.24 84.16% | 0.26 209.60% | -1.12 526.42% | |
ev to sales | -4.71 - | 29.61 - | ||||||||
free cash flow per share | -11.84 - | -23.40 97.63% | -81.23 247.18% | -89.19 9.80% | -4.18 95.31% | -3.00 28.34% | -2.78 7.34% | -1.22 56.25% | -0.54 55.31% | |
free cash flow yield | -0.14 - | -0.28 97.63% | -1.06 281.73% | -6.41 503.90% | -0.39 93.90% | -0.47 19.25% | -1.21 160.19% | -1.22 0.91% | -0.65 47.08% | |
graham net net | -38.70 - | -64.12 65.66% | 161.88 352.49% | 40.29 75.11% | 8.34 79.29% | 1.46 82.50% | 1.15 21.34% | 0.65 43.76% | 0.11 83.70% | |
graham number | 108.87 - | 184.26 69.25% | 615.58 234.08% | 315.03 48.82% | 35.18 88.83% | 15.89 54.84% | 13.92 12.37% | 6.23 55.29% | 1.92 69.19% | |
income quality | 0.82 - | 0.94 15.10% | 0.82 12.65% | 0.95 15.57% | 0.91 4.29% | 0.95 4.03% | 0.80 15.56% | 0.82 2.75% | 0.95 16.14% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.17 Infinity% | 0.22 30.79% | 0.15 32.88% | 0.11 24.69% | 0.12 5.66% | |
interest coverage | -31.41 - | -9.68 69.18% | -17.38 79.54% | -44.16 154.10% | -24.08 45.47% | -22.27 7.50% | -23.37 4.91% | -21.93 6.15% | -18.61 15.13% | |
interest debt per share | 8.26 - | 19.19 132.25% | 48.39 152.23% | 19.46 59.78% | 2.17 88.83% | 2.05 5.73% | 1.69 17.69% | 0.67 60.41% | 0.35 48.24% | |
inventory turnover | ||||||||||
invested capital | -0.21 - | -0.27 28.96% | 0.25 191.69% | 0.37 47.46% | 0.18 51.48% | 0.53 197.85% | 0.62 16.95% | 0.52 16.00% | 1.09 109.98% | |
market cap | 78.12M - | 78.12M 0% | 26.31M 66.32% | 6.39M 75.71% | 123.37M 1,830.91% | 129.10M 4.64% | 58.97M 54.32% | 63.08M 6.98% | 149.10M 136.35% | |
net current asset value | -35.45M - | -58.45M 64.90% | 58.29M 199.72% | 20.68M 64.53% | 97.80M 373.01% | 33.23M 66.02% | 35.11M 5.65% | 47.14M 34.25% | 25.92M 45.02% | |
net debt to ebitda | -0.04 - | -0.57 1,514.16% | 2.01 454.32% | 0.55 72.85% | 2.35 330.39% | 0.67 71.41% | 0.64 4.77% | 0.94 46.84% | 0.39 58.49% | |
net income per share | -14.24 - | -24.76 73.82% | -98.58 298.19% | -93.73 4.92% | -4.91 94.76% | -3.09 36.96% | -3.44 11.31% | -1.48 57.10% | -0.57 61.50% | |
operating cash flow per share | -11.66 - | -23.32 100.06% | -81.10 247.83% | -89.11 9.87% | -4.17 95.32% | -2.93 29.71% | -2.75 6.00% | -1.21 55.92% | -0.54 55.28% | |
payables turnover | 0.22 - | |||||||||
receivables turnover | 1.22 - | 3.27 - | ||||||||
research and ddevelopement to revenue | 8.85 - | 13.98 - | ||||||||
return on tangible assets | -1.39 - | -3.02 117.38% | -0.42 86.20% | -1.19 186.60% | -0.42 64.54% | -0.65 53.12% | -0.89 36.95% | -0.68 23.58% | -0.78 14.69% | |
revenue per share | 7.63 - | 0.15 - | ||||||||
roe | 0.39 - | 0.41 5.47% | -0.58 242.06% | -1.99 245.15% | -0.44 78.01% | -0.85 94.83% | -1.38 61.34% | -1.27 7.95% | -1.98 56.19% | |
roic | 0.56 - | 0.66 16.76% | -0.52 179.20% | -1.70 226.05% | -0.36 78.92% | -0.52 44.01% | -0.77 50.17% | -0.75 3.44% | -0.98 31.71% | |
sales general and administrative to revenue | 5.26 - | 6.98 - | ||||||||
shareholders equity per share | -36.98 - | -60.95 64.80% | 170.84 380.29% | 47.06 72.45% | 11.21 76.18% | 3.63 67.65% | 2.50 31.01% | 1.17 53.40% | 0.29 75.35% | |
stock based compensation to revenue | 1.61 - | 1.81 - | ||||||||
tangible asset value | -34.32M - | -56.56M 64.80% | 58.71M 203.79% | 21.60M 63.21% | 102.11M 372.74% | 45.69M 55.25% | 47.06M 3.00% | 56.70M 20.48% | 33.75M 40.48% | |
tangible book value per share | -36.98 - | -60.95 64.80% | 170.84 380.29% | 47.06 72.45% | 8.86 81.18% | 2.28 74.30% | 1.83 19.69% | 0.89 51.17% | 0.19 78.74% | |
working capital | 1.71M - | -6.34M 470.99% | 73.15M 1,253.09% | 29.68M 59.42% | 119.83M 303.72% | 71.36M 40.45% | 73.86M 3.50% | 106.35M 44.00% | 99.21M 6.71% |
All numbers in USD (except ratios and percentages)